Literature DB >> 20497189

Clinical involvement in daughters of men with fragile X-associated tremor ataxia syndrome.

W Chonchaiya1, D V Nguyen, J Au, L Campos, E M Berry-Kravis, K Lohse, Y Mu, A Utari, C Hervey, L Wang, P Sorensen, K Cook, L Gane, F Tassone, R J Hagerman.   

Abstract

Women with the fragile X mental retardation 1 (FMR1) premutation often have concerns about neurological and medical problems, as they become older and if their fathers experience fragile X-associated tremor/ataxia syndrome (FXTAS). We therefore determined the prevalence of these problems in 110 daughters of men with FXTAS [mean age of 44.8 years (SD 8.2)]. We compared them with 43 female controls with normal FMR1 alleles [mean age of 43.8 years (SD 8.1)] and 36 premutation carrier daughters of parents with the premutation, but without FXTAS [mean age of 43.5 years (SD 7.7)]. Overall, daughters of men with FXTAS have a higher prevalence of neurological symptoms including tremor, balance problems, memory problems, and dizziness, menopausal symptoms, and psychiatric involvement including sleep problems and anxiety when compared with non-carrier female controls. Reported balance problems and menopausal symptoms were significantly higher in daughters of men with FXTAS than in carrier daughters of parents without FXTAS, suggesting the potential influence of background gene effects. Therefore, neurological, psychological and gynecological surveillance should be warranted to better provide appropriate counseling, management and care for daughters of men with FXTAS. Biological markers of additional gene effects that predispose individuals with the premutation to FXTAS need to be developed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20497189      PMCID: PMC4031089          DOI: 10.1111/j.1399-0004.2010.01448.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  21 in total

1.  Female carriers of fragile X premutations have no increased risk for additional diseases other than premature ovarian failure.

Authors:  R D L Hundscheid; A P T Smits; C M G Thomas; L A L M Kiemeney; D D M Braat
Journal:  Am J Med Genet A       Date:  2003-02-15       Impact factor: 2.802

2.  Abnormal elevation of FMR1 mRNA is associated with psychological symptoms in individuals with the fragile X premutation.

Authors:  David Hessl; Flora Tassone; Danuta Z Loesch; Elizabeth Berry-Kravis; Maureen A Leehey; Louise W Gane; Ingrid Barbato; Cathlin Rice; Emma Gould; Deborah A Hall; James Grigsby; Jacob A Wegelin; Susan Harris; Foster Lewin; Dahlia Weinberg; Paul J Hagerman; Randi J Hagerman
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2005-11-05       Impact factor: 3.568

3.  Initial diagnoses given to persons with the fragile X associated tremor/ataxia syndrome (FXTAS).

Authors:  D A Hall; E Berry-Kravis; S Jacquemont; C D Rice; J Cogswell; L Zhang; R J Hagerman; P J Hagerman; M A Leehey
Journal:  Neurology       Date:  2005-07-26       Impact factor: 9.910

4.  Association of FMR1 repeat size with ovarian dysfunction.

Authors:  A K Sullivan; M Marcus; M P Epstein; E G Allen; A E Anido; J J Paquin; M Yadav-Shah; S L Sherman
Journal:  Hum Reprod       Date:  2004-12-17       Impact factor: 6.918

5.  The emerging fragile X premutation phenotype: evidence from the domain of social cognition.

Authors:  Kim Cornish; Cary Kogan; Jeremy Turk; Tom Manly; Nicole James; Andrea Mills; Ann Dalton
Journal:  Brain Cogn       Date:  2005-02       Impact factor: 2.310

6.  Effect of the fragile X status categories and the fragile X mental retardation protein levels on executive functioning in males and females with fragile X.

Authors:  Danuta Z Loesch; Quang M Bui; Jim Grigsby; Emma Butler; Jennifer Epstein; Richard M Huggins; Annette K Taylor; Randi J Hagerman
Journal:  Neuropsychology       Date:  2003-10       Impact factor: 3.295

Review 7.  The FMR1 premutation and reproduction.

Authors:  Michael D Wittenberger; Randi J Hagerman; Stephanie L Sherman; Allyn McConkie-Rosell; Corrine K Welt; Robert W Rebar; Emily C Corrigan; Joe Leigh Simpson; Lawrence M Nelson
Journal:  Fertil Steril       Date:  2006-10-30       Impact factor: 7.329

Review 8.  Premature ovarian failure in the fragile X syndrome.

Authors:  S L Sherman
Journal:  Am J Med Genet       Date:  2000

9.  A rapid polymerase chain reaction-based screening method for identification of all expanded alleles of the fragile X (FMR1) gene in newborn and high-risk populations.

Authors:  Flora Tassone; Ruiqin Pan; Khaled Amiri; Annette K Taylor; Paul J Hagerman
Journal:  J Mol Diagn       Date:  2007-12-28       Impact factor: 5.568

Review 10.  Fragile X-associated tremor/ataxia syndrome: clinical features, genetics, and testing guidelines.

Authors:  Elizabeth Berry-Kravis; Liane Abrams; Sarah M Coffey; Deborah A Hall; Claudia Greco; Louise W Gane; Jim Grigsby; James A Bourgeois; Brenda Finucane; Sebastien Jacquemont; James A Brunberg; Lin Zhang; Janet Lin; Flora Tassone; Paul J Hagerman; Randi J Hagerman; Maureen A Leehey
Journal:  Mov Disord       Date:  2007-10-31       Impact factor: 10.338

View more
  35 in total

1.  Daily health symptoms of mothers of adolescents and adults with fragile x syndrome and mothers of adolescents and adults with autism spectrum disorder.

Authors:  Leann E Smith; Marsha Mailick Seltzer; Jan S Greenberg
Journal:  J Autism Dev Disord       Date:  2012-09

2.  Prevalence of CGG expansions of the FMR1 gene in a US population-based sample.

Authors:  Marsha Mailick Seltzer; Mei Wang Baker; Jinkuk Hong; Matthew Maenner; Jan Greenberg; Daniel Mandel
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2012-05-22       Impact factor: 3.568

3.  Ages of Onset of Mood and Anxiety Disorders in Fragile X Premutation Carriers.

Authors:  Andreea L Seritan; James A Bourgeois; Andrea Schneider; Yi Mu; Randi J Hagerman; Danh V Nguyen
Journal:  Curr Psychiatry Rev       Date:  2013-02

4.  Newborn screening and cascade testing for FMR1 mutations.

Authors:  Page L Sorensen; Louise W Gane; Mark Yarborough; Randi J Hagerman; Flora Tassone
Journal:  Am J Med Genet A       Date:  2012-12-13       Impact factor: 2.802

5.  Rare intranuclear inclusions in the brains of 3 older adult males with fragile x syndrome: implications for the spectrum of fragile x-associated disorders.

Authors:  Michael R Hunsaker; Claudia M Greco; Flora Tassone; Robert F Berman; Rob Willemsen; Randi J Hagerman; Paul J Hagerman
Journal:  J Neuropathol Exp Neurol       Date:  2011-06       Impact factor: 3.685

6.  Cellular resolution maps of X chromosome inactivation: implications for neural development, function, and disease.

Authors:  Hao Wu; Junjie Luo; Huimin Yu; Amir Rattner; Alisa Mo; Yanshu Wang; Philip M Smallwood; Bracha Erlanger; Sarah J Wheelan; Jeremy Nathans
Journal:  Neuron       Date:  2014-01-08       Impact factor: 17.173

7.  PSYCHIATRIC DISORDERS ASSOCIATED WITH FXTAS.

Authors:  Andreea L Seritan; Melina Ortigas; Stefan Seritan; James A Bourgeois; Randi J Hagerman
Journal:  Curr Psychiatry Rev       Date:  2013

Review 8.  Implications of the FMR1 Premutation for Children, Adolescents, Adults, and Their Families.

Authors:  Anne Wheeler; Melissa Raspa; Randi Hagerman; Marsha Mailick; Catharine Riley
Journal:  Pediatrics       Date:  2017-06       Impact factor: 7.124

Review 9.  Fragile X-associated tremor/ataxia syndrome - features, mechanisms and management.

Authors:  Randi J Hagerman; Paul Hagerman
Journal:  Nat Rev Neurol       Date:  2016-06-24       Impact factor: 42.937

10.  Neurological and endocrine phenotypes of fragile X carrier women.

Authors:  D Hall; K Todorova-Koteva; S Pandya; B Bernard; B Ouyang; M Walsh; T Pounardjian; C Deburghraeve; L Zhou; M Losh; M Leehey; E Berry-Kravis
Journal:  Clin Genet       Date:  2015-09-04       Impact factor: 4.438

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.